logo
AI and robotics expected to play a big role in China's next 5-year plan

AI and robotics expected to play a big role in China's next 5-year plan

China's five-year plan has evolved beyond a command-economy production schedule. It now represents a comprehensive vision for the country's economic future, accompanied by strategies and policy guidelines.
Advertisement
As Beijing's planners draft
the next five-year plan for 2026-2030, a general consensus is emerging: development and economic growth remain paramount. In particular, China is seizing the opportunity to bolster its 'hard power' through manufacturing capabilities and advances in
artificial intelligence
The coming plan is likely to reinforce existing policies that prioritise production. Under themes such as 'high-quality development' and 'new quality productive forces', China is striving to solidify its position as a dominant industrial power integrated into the global economy. Its share of global manufacturing, currently at 30 per cent, could increase as the country has a clear competitive advantage in this area.
China's successful track record in building unparalleled manufacturing capabilities across various industries – from
electric vehicles to
industrial robots – has strengthened Beijing's belief that it is on the right path.
Semiconductor products at an exhibition in Shanghai. Photo: AFP
Its significant control over the rare earth trade shows how even a traditionally polluting industry can be transformed into a strategic asset. Amid
US-China trade negotiations in London , talks of a potential 'rare earth for chips' deal – whereby China would ease rare earth export controls in exchange for relaxed US chip export restrictions – have gained traction on Chinese social media.
Advertisement
At the same time, China is trying to remove so-called choke points in its supply chains, particularly in advanced chips. While its 'whole nation' approach to addressing these vulnerabilities may lead to wasteful duplicate investments, the combination of state support and fierce market competition is enabling China to tackle one bottleneck after another.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

As 2 Hong Kong art spaces seek new leaders, experts weigh in on the impact
As 2 Hong Kong art spaces seek new leaders, experts weigh in on the impact

South China Morning Post

time44 minutes ago

  • South China Morning Post

As 2 Hong Kong art spaces seek new leaders, experts weigh in on the impact

Para Site and Asia Art Archive (AAA), two long-standing independent cultural institutions in Hong Kong, are simultaneously seeking new executive directors at a pivotal moment for the city's cultural scene. On June 2, Para Site in Quarry Bay announced that Billy Tang had stepped down as executive director and curator after concluding his three-year contract. The British-born former senior curator of Shanghai's Rockbund Art Museum took over from Cosmin Costinas – who had run Para Site for 11 years – in May 2022, just as Hong Kong lifted its Covid-19 pandemic ban on non-residents entering the city. Since then, the non-profit art space founded in 1996 has undergone major changes, such as embracing more environmentally friendly and longer-running exhibitions, and opening an additional exhibition space on the 10th floor of the building where it is based which has given emerging artists the chance to undertake more site-specific and interactive projects. Billy Tang stepped down as Para Site's director and curator on June 2, 2025. Meanwhile, AAA in Sheung Wan , which maintains an extensive art archive and runs regular public programmes and a well-used library, put up a job posting for a successor to Christopher K. Ho , who joined AAA as executive director in 2021.

US-China trade showdown: where do the talks stand after Day 1?
US-China trade showdown: where do the talks stand after Day 1?

South China Morning Post

time44 minutes ago

  • South China Morning Post

US-China trade showdown: where do the talks stand after Day 1?

Top officials from China and the United States are expected to start a second day of negotiations in London on Tuesday morning local time, as the two sides strive to de-escalate a stand-off over trade and technology that has sent shock waves across the global economy. No official statements were released after the first round of talks on Monday, which finished without a deal being agreed. But both sides have sent signals regarding their expectations. US Kevin Hassett, director of the National Economic Council, told CNBC that 'immediately after the handshake, any export controls from the US will be eased, and the rare earths will be released in volume, and then we can go back to negotiating smaller matters'. According to a report by the Wall Street Journal, citing people familiar with the matter, US President Donald Trump authorised the American delegation to negotiate away recent restrictions on the sale of advanced technologies and other products to China ahead of the London talks. The recent US export controls cover jet engines and related parts, though these were never publicly announced by Washington; design software Chinese companies need to make advanced microchips; and ethane, a component of natural gas that is used to manufacture plastics, the report said. China

Hong Kong medical device maker to build China plant as US, EU raise trade barriers
Hong Kong medical device maker to build China plant as US, EU raise trade barriers

South China Morning Post

timean hour ago

  • South China Morning Post

Hong Kong medical device maker to build China plant as US, EU raise trade barriers

Vincent Medical Holdings, a Hong Kong-based medical device maker, has doubled down on manufacturing in China by investing in automation and digitalisation, instead of moving operations abroad amid rising trade barriers in the US and Europe. The maker of disposable radiology products and respiratory devices is building a factory in Kaiping in the western part of the Greater Bay Area, CEO Raymond Choi Cheung-tai said in an interview. Trial operations could start before the end of the year, he added. 'We are transforming into a new business model that will give us the flexibility to set up operations in multiple markets to get around the trade barriers,' said Choi, an industrial engineer by training. 'Our new factory will be nearly fully automated, except for some equipment that requires maintenance by technicians.' The firm has a plant in Dongguan in the southern province of Guangdong, which produces 70 million imaging and respiratory consumables and 100,000 hospital electronic respiratory devices annually. The first phase of the new facility was expected to cost HK$200 million (US$25.5 million), it said. Dongguan is one of the nine cities in the province, which together with Hong Kong and Macau, make up the Greater Bay Area - Beijing's vision for a manufacturing and technology powerhouse to drive the nation's economy. Choi joined Vincent Medical in 2020. He is the son of founder and chairman Choi Man-sing, who controls about 60 per cent of the firm. Sales of disposable imaging products grew 38 per cent to HK$393 million last year, or 49 per cent of the group's revenue. The US and Europe contributed almost 40 per cent each to its sales.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store